FINANCIAL SUMMARY - FOURTH QUARTER 2020
MOVING CLOSER TO THE MARKET - PROFESSIONAL SPORTS, CULTURE AND ENTERTAINMENT
Geelmuyden Kiese and KMD announced earlier today that they have entered a partnership to provide smart and efficient Covid-19 test solutions for the professional sports, culture, and entertainment industry. The test capacity will be delivered by Qlife.
The Qlife Covid-19 test has now been implemented by the Danish professional football league (3F Superliga), becoming a guiding light and an inspiration for professional sports, film productions and event organizations to return to business, quickly, efficiently and most importantly safely.
The Scandinavian communications agency Geelmuyden Kiese with deep roots and knowhow in the sports, culture, and entertainment industry, has been appointed partner of the Egoo Health Technology to help professional event and league organizers return to competition as soon as possible.
- Geelmuyden Kiese is an active participant in the industry and cherish the opportunity to help professional event and league organizers return to business as soon as possible. The opportunities with the test kit from Qlife are great news for everyone in the sports, culture, and entertainment business. They now have an opportunity to reopen under controlled circumstances without risking the health of the participants, says Ronnie Hansen, Director of Sports, Culture and Entertainment at Geelmuyden Kiese.
The Egoo system secures a tailored approach that ensures quick and accurate results. It removes burden and responsibility from the public health system and ensures a streamlined process for distribution of results, that can be shared with medical staff and event authorities privately and seamlessly.
The Egoo system meets the conformity assessment requirement under the EU directive for In-Vitro Diagnostics. The product is offered as a RUO (research use only) screening test in accordance with rules set out by the Danish Medicines Agency.
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking.
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit.
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants